Pubblicazioni Scientifiche
Dermatologia28 set 2022
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas
Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma
28 set 2022
Atopic dermatitis and risk of major neuropsychiatric disorders in children
Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities
19 set 2022
Eczema European guideline part II
The evidence- and consensus-based guideline on atopic eczema
19 set 2022
Eczema European guideline part I
The evidence-and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline
19 set 2022
Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities
Cutaneous immune-related adverse events (irAEs) represent the most frequent toxicities
15 set 2022
Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus
Dupilumab has demonstrated a great reduction in chronic pruritus that is the hallmark of atopic dermatitis
15 set 2022
Assessing changes in facial skin quality using
Studies utilizing reflectance confocal microscopy (RCM) and dynamic optical coherence tomography
15 set 2022
Dermoscopy of cutaneous adnexal tumours a systematic review
Cutaneous adnexal tumours (ATs) encompass a variegated group of hamartomas and benign or malignant tumours
05 set 2022
Curettage vs. cryosurgery for superficial basal cell carcinoma
Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence.
05 set 2022
Guidelines for narrowband ultraviolet B phototherapy 2022
British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022
05 set 2022
Updated S2K guidelines on the management of pemphigus vulgaris
Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized
01 ago 2022
Rosacea, an infectious disease
Rosacea and demodicosis are common facial conditions in dermatology practice
01 ago 2022
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
Since the second version of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis
01 ago 2022
Adult atopic eczema and the risk of dementia
Chronic inflammatory conditions have been linked to dementia, but little is known about the role of atopic eczema
27 lug 2022
Monkeypox emerges on a global scale
The current monkeypox outbreak reawakens the concern that poxviridae have high potential of zoonotic spillover and for causing pandemic
27 lug 2022
New insights from non-invasive imaging
The incidence of non-melanoma skin cancer is on the rise and melanoma is among the most common cancers in the United States.
27 lug 2022
Infection risk in psoriatic patients receiving tumour necrosis factor inhibitors
Tumour necrosis factor inhibitors (TNFis) are commonly used for treating psoriatic diseases; however, the risk of infection while receiving TNFis remains uncertain
18 lug 2022
Clinical impact of immunotherapy in Merkel cell carcinoma patients
Immunotherapy is emerging as an alternative treatment for Merkel cell carcinoma, but its long-term effects on response, survival, and safety are not well established.
18 lug 2022
Characteristics and management of skin cancers in very elderly patients
The increase life expectancy led to an expected increase in skin cancer incidence in older patients
18 lug 2022
Updated S2K guidelines on the management of pemphigus
Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin.